In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

STAAR Surgical Company. Trade Record

NASDAQ:STAA STAAR Surgical Company stock gains 6.87% Exit Jan 29, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart STAA Jan 15, 2019, priceSeries
About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Afinity, and AquaFLOW trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, and the United Kingdom, as well as through independent distributors in approximately 60 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
93.17
Entry Date
Jan 15, 2019
Entry Price
31.87
Sell Date
Jan 29, 2019
Sell Price
34.06
Net Gain
6.87%
Hold Time
9 Trading Days